OxyContin billionaire is now trying to get you off OxyContin

Men sit passed out in a park where heroin users gather to shoot up in the Bronx.
(Image credit: Spencer Platt/Getty Images)

The man who made billions by selling the highly addictive drug OxyContin has received a patent to sell an opioid treatment.

Richard Sackler, the former chairman and president of the OxyContin maker Purdue Pharma, is one of six inventors listed on a patent "for a new formulation of buprenorphine," Axios reported Friday. The invention is a variation of buprenorphine, a mild opiate that is often used as an OxyContin substitute and a common treatment for opioid addiction, the Financial Times reports. The patent was granted earlier this year.

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up
To continue reading this article...
Continue reading this article and get limited website access each month.
Get unlimited website access, exclusive newsletters plus much more.
Cancel or pause at any time.
Already a subscriber to The Week?
Not sure which email you used for your subscription? Contact us
Marianne Dodson

Marianne is The Week’s Social Media Editor. She is a native Tennessean and recent graduate of Ohio University, where she studied journalism and political science. Marianne has previously written for The Daily Beast, The Crime Report, and The Moroccan Times.